Clinical Trials Browser

Phase 2 × Extrapancreatic Neuroendocrine Tumor × Tegafur × Clear all

NCT03204032 2017-06-29

A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Extrapancreatic Neuroendocrine Tumor

Phase 2 Unknown

EndocrineGastrointestinalNET

Extrapancreatic Neuroendocrine Tumor